Prediction of in vivo cytotoxicity of chemotherapeutic agents by their effect on malignant leukocytes in vitro.
D001772:Blood Cell Count; D003561:Cytarabine / Q000627:therapeutic use*; D004247:DNA / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D007275:Injections, Intravenous; D007938:Leukemia / Q000188:drug therapy*; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D015122:Mercaptopurine / Q000627:therapeutic use; D009101:Multiple Myeloma / Q000188:drug therapy*; D011241:Prednisone / Q000627:therapeutic use*; D012313:RNA / Q000096:biosynthesis; D014316:Tritium; D014529:Uridine; D014750:Vincristine / Q000627:therapeutic use*
D003561:Cytarabine; D014316:Tritium; D014750:Vincristine; D012313:RNA; D004247:DNA; D015122:Mercaptopurine; D011241:Prednisone; D014529:Uridine